Stockscreener 앱 받기
15.85
1.47%
0.23
시간 외 거래:
15.81
-0.04
-0.25%
전일 마감가:
$15.62
열려 있는:
$15.45
하루 거래량:
31,631
Relative Volume:
0.83
시가총액:
$2.72B
수익:
$603.63M
순이익/손실:
$468.71M
주가수익비율:
5.9098
EPS:
2.682
순현금흐름:
$-59.92M
1주 성능:
+3.59%
1개월 성능:
+16.97%
6개월 성능:
-10.65%
1년 성능:
+11.54%
1일 변동 폭
$15.41
$15.91
1주일 범위
$15.16
$16.33
52주 변동 폭
$11.51
$19.50
Hutchmed China Limited Adr Stock (HCM) Company Profile
명칭
Hutchmed China Limited Adr
전화
-
주소
-
HCM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HCM
Hutchmed China Limited Adr
|
15.85 | 2.69B | 603.63M | 468.71M | -59.92M | 2.682 |
|
ZTS
Zoetis Inc
|
125.08 | 54.31B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.08 | 51.02B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.24 | 45.11B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.41 | 35.98B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
469.77 | 20.15B | 3.08B | 1.24B | 1.07B | 25.61 |
Hutchmed China Limited Adr Stock (HCM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-22 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2025-05-13 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2023-11-24 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2022-05-04 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2021-09-22 | 다운그레이드 | Goldman | Buy → Neutral |
| 2021-08-03 | 개시 | Jefferies | Buy |
| 2020-10-02 | 개시 | Deutsche Bank | Buy |
| 2020-03-13 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-02-20 | 개시 | Goldman | Buy |
| 2019-11-19 | 개시 | CLSA | Buy |
| 2019-10-23 | 재확인 | BofA/Merrill | Buy |
| 2019-07-05 | 개시 | Macquarie | Outperform |
모두보기
Hutchmed China Limited Adr 주식(HCM)의 최신 뉴스
HUTCHMED (NASDAQ:HCM) Shares Gap UpHere's What Happened - MarketBeat
HUTCHMED Highlights Publication of Phase III SACHI Results in The Lancet - GlobeNewswire Inc.
Limoneira Co (NASDAQ:LMNR) Given Average Recommendation of “Hold” by Brokerages - Defense World
Reviewing Just Eat Takeaway.com (OTCMKTS:JTKWY) and Dingdong (Cayman) (NYSE:DDL) - Defense World
Head-To-Head Analysis: Loomis (OTCMKTS:LOIMF) vs. Ryvyl (NASDAQ:RVYL) - Defense World
Tate & Lyle PLC (OTCMKTS:TATYY) Given Average Recommendation of “Hold” by Analysts - Defense World
Urban Edge Properties (NYSE:UE) Given Consensus Recommendation of “Hold” by Brokerages - Defense World
Hawaiian Electric Industries, Inc. (NYSE:HE) Given Consensus Rating of “Hold” by Analysts - Defense World
Compass Diversified Holdings (NYSE:CODI) Given Consensus Recommendation of “Hold” by Brokerages - Defense World
HUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Insmed (NASDAQ:INSM) COO Sells $247,688.57 in Stock - Defense World
CureVac N.V. (NASDAQ:CVAC) Given Consensus Recommendation of “Hold” by Analysts - Defense World
Why HUTCHMED (China) Limited Depositary Receipt stock could see breakout soonJuly 2025 Intraday Action & Stepwise Trade Execution Plans - ulpravda.ru
Wall Street Analysts Predict a 55.93% Upside in HUTCHMED (HCM): Here's What You Should Know - Finviz
HUTCHMED (NASDAQ:HCM) Trading 8.1% HigherHere's What Happened - MarketBeat
HUTCHMED (China) Limited ADR (HCM) Stock Price Today | Live Chart & News - Traders Union
Antofagasta (LON:ANTO) Reaches New 52-Week High – Here’s What Happened - Defense World
HUTCHMED (LON:HCM) Share Price Passes Below 200-Day Moving Average – Here’s What Happened - Defense World
HUTCHMED (NASDAQ:HCM) Sees Strong Trading Volume – Should You Buy? - Defense World
MACD Signals Flash Warning for The Hindustan Housing Company Limited StockMarket Entry Points & Free Navigate Market With Precision - bollywoodhelpline.com
HUTCHMED (NASDAQ:HCM) Sees Large Volume IncreaseShould You Buy? - MarketBeat
[6-K] HUTCHMED (China) Ltd Current Report (Foreign Issuer) | HCM SEC FilingForm 6-K - Stock Titan
REGHutchmed China LtdBlocklisting Six Monthly Return - TradingView — Track All Markets
HUTCHMED (NASDAQ:HCM) Sees Strong Trading VolumeTime to Buy? - MarketBeat
Brokerages Set HUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM) Target Price at $20.88 - Defense World
HUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
HUTCHMED Initiates Global Clinical Development of ATTC Candidate HMPL-A251 in Patients with Solid Tumors - GlobeNewswire
HUTCHMED Announces Expanded Coverage on National Reimbursement Drug List and Inclusion in the First Commercial Insurance Drug List in China - Chartmill
Bearish block trade of HUTCHMED(00013) 278.5K shares at $22.0, $6.127M turnover - AASTOCKS.com
Schroder Investment Management Group Has $38.82 Million Stock Holdings in HUTCHMED (China) Limited Sponsored ADR $HCM - MarketBeat
HUTCHMED Share Movement in the (LSE:HCM) Landscape and FTSE Aim 100 - Kalkine Media
Forge Global Holdings, Inc. (NYSE:FRGE) Receives $42.00 Average Price Target from Analysts - Defense World
Rep. Lisa C. McClain Sells Off Shares of Gartner, Inc. (NYSE:IT) - Defense World
HUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Catalyst Funds Management Pty Ltd Sells 29,903 Shares of HUTCHMED (China) Limited Sponsored ADR $HCM - MarketBeat
ABN Amro Investment Solutions Invests $962,000 in HUTCHMED (China) Limited Sponsored ADR $HCM - MarketBeat
HMPL-A251 combines HER2 targeting with precision payload - BioWorld MedTech
Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing - The Globe and Mail
Transcript : HUTCHMED Limited Presents at Deutsche Bank ADR Virtual Investor Conference 2025, Nov-04-2025 08 - MarketScreener
HUTCHMED (China) Limited (HCM) HUTCHMED (China) Limited Presents at Deutsche Bank ADR Virtual Investor Conference 2025Slideshow (NASDAQ:HCM) 2025-11-04 - Seeking Alpha
Hutchmed Strengthens Position Within FTSE AIM 100 Index Healthcare Sphere - Kalkine Media
HUTCHMED Announces Enrollment Completed of SAFFRON Global - GlobeNewswire
Hutchmed takes wraps off expanding oncology pipeline - Sharecast.com
Market news - investments.halifax.co.uk
HUTCHMED Highlights Pipeline and Business Progress at R&D Updates Event - The Manila Times
RCSHutchmed China LtdUpdates from R&D Event - TradingView
ETFs Investing in HUTCHMED (China) Limited Sponsored ADR Stocks - TradingView
CORRECTION -- International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on November 04, 2025 - The Manila Times
Hutchmed China Limited Adr (HCM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
9.91%
2.63%
자본화:
|
볼륨(24시간):